Germicidal face mask
View Patent ↗A face mask for reducing the amount of microbes to which a wearer is exposed is provided. The face mask includes a body portion that has an outer layer that has been treated with a germicidal agent in an effective amount. The layer may be a nonwoven fabric like a spunbond, meltblown or coform layer and may be a laminate of such layers. The face mask having such a germicidal treatment can result in a reduction in microbial activity as compared to another face mask, identical but for the germicidal agent.
1. A face mask comprising:
a fastening member for attaching a body portion of the face mask to the users; and
a body portion joined to the fastening member and configured to be placed over a mouth and at least part of a nose of a user in such that respiration air is drawn through said body portion,
the body portion comprising a plurality of layers with at least an outermost layer having a germicidal agent comprising polyhexamethylene biguanide, citric acid and N-alkyl polyglycoside and wherein the germicidal agent containing layers of the body portion have a percent solids add-on of polyhexamethylene biguanide between 0.01 and 20 weight percent, a percent solids add-on of citric acid between 0.01 and 10 weight percent; and a percent solids add-on of N-alkyl polyglycoside between 0.01 and 10 weight percent.
2. The face mask as set forth in claim 1 , wherein the germicidal agent on the body portion of the face mask further includes at least one additional ingredient selected from quaternary ammonium compounds, quaternary ammonium siloxanes, polyquaternary amines, metal-containing species and oxides thereof, halogens, halogen-releasing agents, halogen-containing polymers, bromo-compounds, chlorine dioxides, thiazoles, thiocynates, isothiazolins, cyanobutanes, dithiocarbamates, thiones, alkylsulfosuccinates, alkyl-amino-alkyl glycines, dialkyl-dimethyl-phosphonium salts, cetrimides, hydrogen peroxide, 1-alkyl-1,5-diazapentane, cetyl pyridinium chloride, stabilized oxidants, stabilized peroxides, sulfides, bis-phenols, polyphenols, chitosan, anatase TiO 2 , tourmaline, bamboo extract, neem oil, hydrotropes, chaotropic agents and combinations thereof.
3. The face mask as set forth in claim 1 , wherein at least the body portion of the face mask is treated with said germicidal agent by the method selected from the group consisting of dipping and squeezing, spraying, ink jet printing and combinations thereof.
4. The face mask as set forth in claim 1 , wherein the outermost layer comprises a nonwoven web.
5. The face mask as set forth in claim 4 , wherein said nonwoven web is selected from the group consisting of spunbond webs and wet laid polyester webs.
6. The face mask of claim 1 wherein the germicidal agent on the body portion of the face mask further includes an ingredient selected from chitosan glycolate, octadecylaminodimethyl trimethoxysilylpropyl ammonium chloride, PG-hydroxyethylcellulose cocodimonium chloride, xylitol, benzoic acid, salycilic acid, acetic acid, glutaric acid, iodine, ethyl hydroxyethyl cellulose, polyvinyl pyrrolidone, poly(vinyl pyrrolidone-co-vinyl acetate), polyvinyl pyrrolidone-Iodine complex, guanidine hydrochloride and sorbitol, acrylic co-polymer compound and isopropyl alcohol, copper oxide, silver sodium hydrogen zirconium phosphate, silver zinc glass, barium sulfate and combinations thereof.
7. The face mask of claim 1 wherein said mask has a particle filtration efficiency as measured by ASTM F-2299 greater than 85%, a bacteria filtration efficiency as measured by ASTM F-2101 greater than 85%, and a differential pressure drop as measured by ASTM F-2101 less than 8 mm water/square cm.
8. The mask of claim 1 wherein said mask exhibits a 3 log 10 reduction of microbes on the surface of said mask when said mask is insulted with an innoculum selected from the group consisting of MRSA Staphylococcus aureus (ATCC#33591), VRE Enterococcus faecalis (ATCC#51299), Moraxella catarrhalis (ATCC #8176), Klebsiella pneumoniae (ATCC#4352), Candida albicans (ATCC#10231), Rhinovirus 1A (ATCC# VR-1364), Influenza A (ATCC# VR-1469) within 30 minutes of contact with said mask.
9. The face mask of claim 1 wherein said mask exhibits a 3 log 10 reduction in contact transfer of an innoculum selected from the group consisting of MRSA Staphylococcus aureus (ATCC#33591), VRE Enterococcus faecalis (ATCC#51299), Moraxella catarrhalis (ATCC #8176), Klebsiella pneumoniae (ATCC#4352), Candida albicans (ATCC#10231), Rhinovirus 1A (ATCC# VR-1364), Influenza A (ATCC# VR-1469) within 30 minutes of contact with said mask.
10. A face mask comprising:
a fastening member for attaching a body portion of the face mask to the users; and
a body portion joined to the fastening member and configured to be placed over a mouth and at least part of a nose of a user in such that respiration air is drawn through said body portion, the body portion comprising a plurality of layers with at least an outermost layer being a polyolefin nonwoven web having a germicidal agent comprising polyhexamethylene biguanide, citric acid and N-alkyl polyglycoside and wherein the germicidal agent containing layers of the body portion have a percent solids add-on of polyhexamethylene biguanide between 0.01 and 20 weight percent, percent solids add-on of citric acid between 0.01 and 10 weight percent; and a percent solids add-on of N-alkyl polyglocoside a between 0.01 and 10 weight percent.
11. The face mask of claim 10 , wherein the polyolefin nonwoven web is a spunbonded nonwoven web made from a polyolefin selected from polyethylene and polypropylene.